Mayo Clinic researchers have found that an artificial intelligence (AI) tool may provide dermatologists with additional information to help assess whether skin lesions are cancerous and inform their ...

The skin cancer vaccine is based on mRNA technology that helped end the coronavirus pandemic.

The results of a late-stage trial showed an experimental vaccine slashed the risk that melanoma returns by 42 per cent.

The treatment is still experimental, but results from Moderna and Merck add scientific support for a vaccine-based approach ...

A first-of-its-kind vaccine against cancer may be on the horizon.

The results, which triggered Moderna’s stock to drop, are “really encouraging,” says Karen Knudsen, CEO of the Parker ...

Moderna shares are taking a hit after the leak of highly anticipated details about the company’s vaccine for the skin cancer ...

For years, families affected by blood cancers such as leukemia and lymphoma often had no clear answers when multiple relatives developed similar diseases.

A first-of-its-kind cancer vaccine is helping significantly reduce the chances that melanoma patients' tumors return ...

Hilária Mireski, who has the rare Gorlin-Goltz syndrome and has been diagnosed with 73 skin cancers, wed Adão Pereira wed in ...

Personalized mRNA vaccines against melanoma—the deadliest form of skin cancer—reduced the risk of death or recurrence by 42 ...

A study pitted three AI diagnostic systems against 652 physicians using 1,117 standardized cases. Experienced dermatologists came out ahead.